The metabolic nature of the driver mutations in SDHd-RCC and fumarate hydratase-deficient FHd-RCC results in these subtypes being of particular interest for the exploration of metabolic heterogeneity. The gene discussed is SDHD; the disease is renal cell adenocarcinoma.